Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease
Naser-Aldin Lashgari, Nazanin Momeni Roudsari, Saeideh Momtaz, et al.
Journal of Neuroimmunology (2021) Vol. 361, pp. 577758-577758
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions
Alexey Sarapultsev, Evgeni Gusev, Maria Komelkova, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 52
Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson’s disease
Qiankun Lv, Kang‐Xin Tao, Xiaobo Wang, et al.
Inflammation Research (2023) Vol. 72, Iss. 3, pp. 443-462
Closed Access | Times Cited: 50
Regulation of the microglial polarization for alleviating neuroinflammation in the pathogenesis and therapeutics of major depressive disorder
Yufei Wang, Cong-Ya Chen, Lan Lei, et al.
Life Sciences (2025) Vol. 362, pp. 123373-123373
Closed Access | Times Cited: 2
Quercetin as a JAK–STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases
Hamidreza Zalpoor, Mohsen Nabi‐Afjadi, Razieh Forghaniesfidvajani, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40
Current Treatments and New, Tentative Therapies for Parkinson’s Disease
Teresa Pardo-Moreno, Victoria García‐Morales, Nora Suleiman‐Martos, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 770-770
Open Access | Times Cited: 38
The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids
Leila Kooshki, Seyede Nazanin Zarneshan, Sajad Fakhri, et al.
Phytomedicine (2023) Vol. 112, pp. 154686-154686
Closed Access | Times Cited: 35
Mitigating neurological, cognitive, and psychiatric sequelae of COVID-19-related critical illness
Pratik P. Pandharipande, Shawniqua Williams Roberson, Fiona E. Harrison, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 8, pp. 726-738
Open Access | Times Cited: 31
Gut-brain axis interplay via STAT3 pathway: Implications of Helicobacter pylori derived secretome on inflammation and Alzheimer’s disease
Meenakshi Kandpal, Budhadev Baral, Nidhi Varshney, et al.
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Impact of polystyrene nanoplastics on apoptosis and inflammation in zebrafish larvae: Insights from reactive oxygen species perspective
Jincheng Pei, Shannan Chen, Li Li, et al.
The Science of The Total Environment (2024) Vol. 948, pp. 174737-174737
Closed Access | Times Cited: 6
Inflammatory hallmarks in 6-OHDA- and LPS-induced Parkinson's disease in rats
Zhanna Oliynyk, Mariia Rudyk, Taisa Dovbynchuk, et al.
Brain Behavior & Immunity - Health (2023) Vol. 30, pp. 100616-100616
Open Access | Times Cited: 14
Unraveling Dysregulated Cell Signaling Pathways, Genetic and Epigenetic Mysteries of Parkinson’s Disease
Shayesteh Kokabi Hamidpour, Mobina Amiri, Arsh Haj Mohamad Ebrahim Ketabforoush, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 5
Ginsenoside Rg1 improves autophagy dysfunction to ameliorate Alzheimer's disease via targeting FGR proto-oncogene
Qiankun Quan, Xinxin Ma, Jundong Feng, et al.
Neuropeptides (2025) Vol. 111, pp. 102514-102514
Closed Access
Unraveling the role of the IL-20 cytokine family in neurodegenerative diseases: Mechanisms and therapeutic insights
Pouya Goleij, Afshin Amini, Mohammad Amin Khazeei Tabari, et al.
International Immunopharmacology (2025) Vol. 152, pp. 114399-114399
Closed Access
Application of curcuminoids in inflammatory, neurodegenerative and aging conditions - Pharmacological potential and bioengineering approaches to improve efficiency
Ricardo Lagoa, Rajan Logesh, Cristiana Violante, et al.
Biotechnology Advances (2025), pp. 108568-108568
Open Access
JAK/STAT inhibitors mitigate sepsis‐associated cerebral and cognitive injury
Mohini Singh Bhadauriya, Harshita Singh, Manisha Suri, et al.
Fundamental and Clinical Pharmacology (2025) Vol. 39, Iss. 3
Closed Access
<b><i>Cannabis sativa</i></b> and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?
Milena de Barros Viana, Pedro Everson Alexandre de Aquino, Débora Estadella, et al.
Medical Cannabis and Cannabinoids (2022) Vol. 5, Iss. 1, pp. 207-219
Open Access | Times Cited: 20
Tetrastigma hemsleyanum polysaccharide ameliorates cytokine storm syndrome via the IFN-γ-JAK2/STAT pathway
Siyu Fu, Xiaodan Bao, Zian Mao, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133427-133427
Closed Access | Times Cited: 4
Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases
Naser‐Aldin Lashgari, Nazanin Momeni Roudsari, Seyed Saeed Tamehri Zadeh, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 57-75
Open Access | Times Cited: 18
Dexmedetomidine pretreatment alleviates cerebral ischemia/reperfusion injury by inhibiting neuroinflammation through the JAK2/STAT3 pathway
Huan Liu, Jianli Li, Li Jiang, et al.
Brazilian Journal of Medical and Biological Research (2022) Vol. 55
Open Access | Times Cited: 16
Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis
Dimitrios S. Mysiris, George D. Vavougios, Eirini Karamichali, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9739-9739
Open Access | Times Cited: 16
REST Targets JAK–STAT and HIF-1 Signaling Pathways in Human Down Syndrome Brain and Neural Cells
Tan Huang, Sharida Fakurazi, Pike-See Cheah, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9980-9980
Open Access | Times Cited: 10
Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship
Lalmohan Maji, Sindhuja Sengupta, Gurubasavaraja Swamy Purawarga Matada, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
Neuroprotective Effect of Maresin-1 in Rotenone-Induced Parkinson’s Disease in Rats: The Putative Role of the JAK/STAT Pathway
Suzan A Khodir, Eman Sweed, Manar A. Faried, et al.
Neurochemical Research (2024) Vol. 50, Iss. 1
Open Access | Times Cited: 3
What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?
Jinsong Xue, Keju Tao, Weijia Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1641-1641
Open Access | Times Cited: 2
Nanoplastics and chrysene pollution: Potential new triggers for nonalcoholic fatty liver disease and hepatitis, insights from juvenile Siniperca chuatsi
Tiantian Chen, He‐wei Jiang, Yaoji He, et al.
The Science of The Total Environment (2024) Vol. 922, pp. 171125-171125
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top